Michael Nohaile - 15 May 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Director
Signature: /s/ Paul Kim as Attorney-in-Fact
Issuer symbol: FLGT
Transactions as of: 15 May 2025
Net transactions value: $0
Form type: 4
Filing time: 19 May 2025, 17:32:58 UTC
Previous filing: 20 May 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nohaile Michael	Director	C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE	/s/ Paul Kim as Attorney-in-Fact	19 May 2025	0001890563

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Award	$0	+4,491	+31%	$0.000000	19,020	15 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLGT	Stock Option (Right to Buy)	Award	$0	+6,311		$0.000000	6,311	15 May 2025	Common Stock	6,311	$20.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
F2	The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.